Elaine Young

Oct 9, 2024 | touchendocrinology.com | Mahima Chillakanti |Elaine Young |April Hopcroft |Natalie Bellini

Overview BackgroundDiabetes during pregnancy is associated with significant maternal and foetal health risks. Insulin requirements also change during pregnancy. This necessitates careful and effective management of diabetes. Although commonly used in clinical practice, the US Food and Drug Administration (FDA)-approved algorithms for automated insulin delivery (AID) systems do not have pregnancy-specific glycaemic targets.